Novo Nordisk staff cull swells to 1,300

Novo Nordisk has raised the number of staff it will shed this year in order to invest more in developing new drugs and supporting its most important products.

The Danish drugmaker said in September that it would shed around 400 workers in Denmark and China and another 250 in the US, but now says it expects to have shed 1,300 staff by the end of the year, with most of those reductions already implemented.